Can Teva Pharmaceutical Turn Around Under New CEO?

Lisensi Anda Salah atau Anda belum memasukkan Lisensi

Source : http://www.investopedia.com/news/can-teva-pharmaceutical-turn-around-under-new-ceo/

Can Teva Pharmaceutical Turn Around Under New CEO?
Teva's new CEO faces daunting task in turnaround bid
With $40 Million Pay, Teva Breaks From Custom for Turnaround
Teva finally nabs a CEO, and it's Lundbeck helmsman—and Novo ex—Kåre Schultz
Teva Pharmaceuticals Finally Has Some Positive News
Halozyme, Inovalon, and Teva Soared This Week: Can They Go Higher?
Teva Hires Kare Schultz as CEO: Is a Recovery in the Cards?
Teva Fills CEO Spot After Long Search -- WSJ
Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Nuvelution Pharma, Inc.
Can a New CEO Turn Around Teva?